Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 1
2015 1
2019 2
2020 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
Modi S, Saura C, Yamashita T, Park YH, Kim SB, Tamura K, Andre F, Iwata H, Ito Y, Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im SA, Lee KS, Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I; DESTINY-Breast01 Investigators. Modi S, et al. N Engl J Med. 2020 Feb 13;382(7):610-621. doi: 10.1056/NEJMoa1914510. Epub 2019 Dec 11. N Engl J Med. 2020. PMID: 31825192 Free PMC article. Clinical Trial.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
André F, Hee Park Y, Kim SB, Takano T, Im SA, Borges G, Lima JP, Aksoy S, Gavila Gregori J, De Laurentiis M, Bianchini G, Roylance R, Miyoshi Y, Armstrong A, Sinha R, Ruiz Borrego M, Lim E, Ettl J, Yerushalmi R, Zagouri F, Duhoux FP, Fehm T, Gambhire D, Cathcart J, Wu C, Chu C, Egorov A, Krop I. André F, et al. Among authors: gavila gregori j. Lancet. 2023 May 27;401(10390):1773-1785. doi: 10.1016/S0140-6736(23)00725-0. Epub 2023 Apr 20. Lancet. 2023. PMID: 37086745 Clinical Trial.
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Ayala de la Peña F, Antolín Novoa S, Gavilá Gregori J, González Cortijo L, Henao Carrasco F, Martínez Martínez MT, Morales Estévez C, Stradella A, Vidal Losada MJ, Ciruelos E. Ayala de la Peña F, et al. Among authors: gavila gregori j. Clin Transl Oncol. 2023 Sep;25(9):2647-2664. doi: 10.1007/s12094-023-03215-4. Epub 2023 Jun 16. Clin Transl Oncol. 2023. PMID: 37326826 Free PMC article.
[Euthanasia in patients with cancer and the continuous-care providers].
Camps Herrero C, Gavilá Gregori J, Garde Noguera J, Caballero Díaz C, Iranzo González-Cruz V, Juárez Marroquí A, Safont Aguilera MJ, Blasco Cordellat A, Berrocal Jaime A, Sanz de Bremond MG. Camps Herrero C, et al. Among authors: gavila gregori j. Clin Transl Oncol. 2005 Aug;7(7):278-84. doi: 10.1007/BF02710266. Clin Transl Oncol. 2005. PMID: 16185589 Review. Spanish.
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Ayala de la Peña F, Antolín Novoa S, Gavilá Gregori J, González Cortijo L, Henao Carrasco F, Martínez Martínez MT, Morales Estévez C, Stradella A, Vidal Losada MJ, Ciruelos E. Ayala de la Peña F, et al. Among authors: gavila gregori j. Clin Transl Oncol. 2024 Feb;26(2):555-556. doi: 10.1007/s12094-023-03334-y. Clin Transl Oncol. 2024. PMID: 37902930 Free PMC article. No abstract available.
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial.
Salvador Bofill J, Moreno Anton F, Rodriguez Sanchez CA, Galve Calvo E, Hernando Melia C, Ciruelos Gil EM, Vidal M, Jiménez-Rodriguez B, De la Cruz Merino L, Martínez Jañez N, Villanueva Vazquez R, de Toro Salas R, Anton Torres A, Alvarez Lopez IM, Gavila Gregori J, Quiroga Garcia V, Vicente Rubio E, De la Haba-Rodriguez J, Gonzalez-Santiago S, Diaz Fernandez N, Barnadas Molins A, Cantos Sanchez de Ibargüen B, Delgado Mingorance JI, Bellet Ezquerra M, de Casa S, Gimeno A, Martin M. Salvador Bofill J, et al. Among authors: gavila gregori j. Breast. 2022 Dec;66:77-84. doi: 10.1016/j.breast.2022.09.006. Epub 2022 Sep 28. Breast. 2022. PMID: 36206609 Free PMC article. Clinical Trial.
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.
Lope V, Guerrero-Zotano A, Ruiz-Moreno E, Bermejo B, Antolín S, Montaño Á, Baena-Cañada JM, Ramos Vázquez M, Fernández de Larrea-Baz N, Chacón JI, García-Sáenz JA, Olier C, Muñoz M, Antón A, Sánchez Rovira P, Arcusa Lanza A, González S, Oltra A, Brunet J, Gavilá Gregori J, Martínez MT, Calvo L, Rosell L, Bezares S, Pastor-Barriuso R, Pérez-Gómez B, Martín M, Pollán M. Lope V, et al. Among authors: gavila gregori j. Cancers (Basel). 2022 Sep 27;14(19):4705. doi: 10.3390/cancers14194705. Cancers (Basel). 2022. PMID: 36230628 Free PMC article.
Breast cancer in pregnancy: an institutional experience.
Blanquisett AH, Vicent CH, Gregori JG, Zotano ÁG, Porta VG, Simón AR. Blanquisett AH, et al. Among authors: gregori jg. Ecancermedicalscience. 2015 Jul 8;9:551. doi: 10.3332/ecancer.2015.551. eCollection 2015. Ecancermedicalscience. 2015. PMID: 26284115 Free PMC article.
Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists.
Sánchez-Rovira P, Zamora P, Salvador-Bofill J, Morales S, Martínez-Jáñez N, Martínez-de-Dueñas E, Lluch A, Illarramendi JJ, Gómez-Pardo P, Gavilá Gregori J, García-Palomo A, García-Mata J, Fernández Y, Del Barco S, de Juan A, Ciruelos E, Chacón JI, Calvo L, Barnadas A, Albanell J. Sánchez-Rovira P, et al. Among authors: gavila gregori j. J Drug Assess. 2019 Apr 8;8(1):62-69. doi: 10.1080/21556660.2019.1604375. eCollection 2019. J Drug Assess. 2019. PMID: 31069129 Free PMC article.
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.
Alberola Candel V, Carrato Mena A, Díaz-Rubio García E, Gascón Vilaplana P, González Barón M, Martín Jiménez M, Alba Conejo E, Cassinello Espinosa J, Colomer R, Cruz Hernández JJ, Barnadas i Molins A, Camps Herrero C, Casas Fernández de Tejerina AM, Carulla Torrent J, Constenla Figueiras M, Gavilá Gregori J, Isla Casado MD, Massuti Sureda B, Provencio Pulla M, Rodríguez Sánchez CA, Sanz Ortiz J; Spanish Society of Medical Oncology. Alberola Candel V, et al. Among authors: gavila gregori j. Clin Transl Oncol. 2009 Nov;11(11):727-36. doi: 10.1007/s12094-009-0435-6. Clin Transl Oncol. 2009. PMID: 19917536